The US HIV Epidemic: Why Is Prevention Failing?
Source: HIV/AIDS Annual Update 2008


Thomas J. Coates, PhD, reviews the current epidemiology of HIV infection in the United States and discusses the most recent developments in strategies to prevent HIV transmission.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Describe the differential impacts of the HIV epidemic on US racial and geographic groups
  • Discuss the advantages and disadvantages of current HIV prevention approaches
  • Describe the current Centers for Disease Control and Prevention recommendations for HIV screening and testing
  • Discuss the role of healthcare providers in HIV prevention efforts

Topics covered include:

  • Introduction
  • Epidemiology of HIV in the United States
  • Challenges in HIV Prevention
  • HIV Prevention Science: Successes and Difficulties
  • Expanded Routine HIV Testing Recommendations
  • Detecting New HIV Infections
  • Healthcare Providers' Role in HIV Prevention
  • A Holistic Perspective: Focus on Highly Active HIV Prevention
  • Goal: Reducing US HIV Incidence From 60,000 to 30,000 per Year
  • A Final Word: Implement HIV Prevention
  • Summary: Implications for Clinical Practice


  • Thomas J. Coates

Credit Information

  • Release Date:
    June 02, 2008
  • Expiration Date:
    June 01, 2009
  • Physicians:
    maximum of 0.75 AMA PRA Category 1 Credits
  • Registered Nurses:
    0.8 Nursing contact hours
  • What to Make of the “Functional Cure” of HIV in an Infant

    W. David Hardy MD - 3/28/2013    10 comments / Last Comment: 4/8/2014
    Does this report from CROI have implications for how we manage HIV-exposed infants?
  • Postexposure Prophylaxis: Dealing With Old Guidelines

    Eric S. Daar MD - 2/22/2013    9 comments / Last Comment: 3/10/2014
    While data continues to evolve in HIV research, how do you deal with guidelines that have not yet been updated?
  • PrEP at CROI 2013: How Does This Influence Our Practice?

    Eric S. Daar MD - 3/21/2013    2 comments / Last Comment: 5/28/2013
    Although PrEP can be effective in preventing HIV acquisition, the latest data from CROI further underscore the critical importance of adherence in determining efficacy.
  • The Shifting Sands of HIV Risk in the US Today: Falling in Women, Rising in Young MSM

    W. David Hardy MD - 2/28/2013    1 comment / Last Comment: 3/15/2013
    The trends I’ve seen in my own practice are consistent with recent data from the CDC on the evolving impact of HIV in the US population.
  • What the iPrEX Study Taught Me About Adherence Counseling

    Kevin M. O'Hara MMSc, MS, PA-C - 10/24/2014    2 comments / Last Comment: 4/21/2015
    iPrEX OLE showed that perfect adherence was not required to attain the benefits of PrEP. How should that influence our approach to adherence counseling for our patients?